Cimzia
certolizumab pegol · KIT · UCB, Inc.
No Recall History
Plain English
Cimzia is a kit containing certolizumab pegol. Manufactured by UCB, Inc..
Key Facts
- Brand Name
- Cimzia
- Generic Name
- certolizumab pegol
- NDC Code (Product)
50474-700- Manufacturer
- UCB, Inc.
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125160
- Drug Class
- Tumor Necrosis Factor Blocker [EPC]
- Marketing Start
- 04/20/2008
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
drug ineffective26,772 reports
rheumatoid arthritis19,436 reports
pain15,698 reports
fatigue13,479 reports
off label use11,345 reports
rash10,935 reports
arthralgia10,779 reports
alopecia10,079 reports
joint swelling9,728 reports
abdominal discomfort9,492 reports
Frequently Asked Questions
What is Cimzia used for?
Cimzia contains certolizumab pegol. It is a kit taken as directed. Consult your doctor for specific uses.
Is Cimzia a controlled substance?
Cimzia is not classified as a controlled substance by the DEA.
What is the generic name for Cimzia?
The generic name for Cimzia is certolizumab pegol. There are no other listed brand versions of certolizumab pegol.
What is the NDC code for Cimzia ?
The NDC (National Drug Code) for Cimzia is 50474-700, listed by UCB, Inc..
Other Cimzia Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)